PPG INDUSTRIES INC
10-Q, 1994-08-15
PAINTS, VARNISHES, LACQUERS, ENAMELS & ALLIED PRODS
Previous: PITNEY BOWES INC /DE/, 10-Q, 1994-08-15
Next: PS GROUP INC, 10-Q, 1994-08-15





<PAGE>
				 
		    SECURITIES AND EXCHANGE COMMISSION
			  WASHINGTON, D.C. 20549


				 FORM 10-Q


		QUARTERLY REPORT UNDER SECTION 13 or 15(d)
		  OF THE SECURITIES EXCHANGE ACT OF 1934


For Quarter Ended  June 30, 1994           Commission File Number  1-1687


			   PPG INDUSTRIES, INC.                            
	  (Exact name of registrant as specified in its charter)


	Pennsylvania                                         25-0730780    
(State or other jurisdiction of                          (I.R.S. Employer
 incorporation or organization)                         Identification No.)



One PPG Place, Pittsburgh, Pennsylvania                            15272   
(Address of principal executive offices)                         (Zip Code)




Registrant's telephone number, including area code      (412) 434-3131     



As of July 31, 1994, 212,581,107 shares of the Registrant's common stock, par 
value $1.66-2/3 per share, were outstanding.

Indicate by check mark whether the Registrant (1) has filed all reports 
required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 
1934 during the preceding 12 months, and (2) has been subject to such filing 
requirements for the past 90 days.


		    Yes   X                 No      






<PAGE>

			   PPG INDUSTRIES, INC.
		       AND CONSOLIDATED SUBSIDIARIES
		       =============================


				   Index


Part I.  Financial Information                                        Page(s)


  Item 1.  Financial Statements:

    Condensed Statement of Operations................................   2 - 3

    Condensed Balance Sheet..........................................       4

    Condensed Statement of Cash Flows................................       5

    Notes to Condensed Financial Statements..........................   6 - 9

  Item 2.  Management's Discussion and Analysis of Financial
	   Condition and Results of Operations....................... 10 - 16


Part II.  Other Information


Item 6.  Exhibits and Reports on Form 8-K..........................      17


Signature............................................................      18
















				    - 1 -


<PAGE>

		      Part I.  FINANCIAL INFORMATION

Item 1.  Financial Statements

		   PPG INDUSTRIES, INC. AND SUBSIDIARIES
<TABLE>
	       Condensed Statement of Operations (Unaudited)
<CAPTION>
				   Three Months            Six Months
				   Ended June 30          Ended June 30
				  1994       1993        1994       1993
						(Millions)
<S>                             <C>        <C>         <C>        <C>
Net sales.....................  $1,619.3   $1,523.6    $3,096.2   $2,970.3
Cost of sales.................     987.9      965.8     1,899.7    1,879.8
  Gross profit................     631.4      557.8     1,196.5    1,090.5

Other expenses:
  Selling, general and
    administrative............     223.4      223.4       439.5      440.9
  Depreciation................      79.0       84.0       157.5      168.6
  Research and development....      54.5       50.7       103.4      101.0
  Interest....................      22.4       25.4        44.2       53.4
  Other charges...............      28.5       15.1        43.6       36.1
  Business divestitures
    and realignments (Note 4).      85.0         .7        85.0        1.4

Total other expenses..........     492.8      399.3       873.2      801.4

Other earnings................      22.6       26.0        47.5       82.3

Income before income taxes
  and minority interest.......     161.2      184.5       370.8      371.4

Income taxes..................      60.9       73.8       144.7      148.5

Minority interest.............       4.1        4.5         8.0        6.6

Income before cumulative
  effect of accounting
  changes.....................      96.2      106.2       218.1      216.3

Cumulative effect of
  accounting changes (Note 2):
    Other postretirement and
      postemployment bene-
      fits, net of income
      taxes of $231.9 million.        --         --          --     (363.2)
    Income taxes..............        --         --          --       90.4

Net income (loss).............  $   96.2   $  106.2    $  218.1   $  (56.5)


</TABLE>
				    - 2 -

<PAGE>


		   PPG INDUSTRIES, INC. AND SUBSIDIARIES

	       Condensed Statement of Operations (Unaudited)
<TABLE>
				(Continued)
<CAPTION>
				   Three Months            Six Months
				   Ended June 30          Ended June 30
				  1994       1993        1994       1993
<S>                             <C>        <C>         <C>        <C>
Earnings (loss) per share:
  Income before cumulative
    effect of accounting
    changes...................  $   0.46   $   0.50    $   1.03   $   1.02
  Cumulative effect of
    accounting changes:
      Other postretirement
	and postemployment
	benefits..............        --         --          --      (1.71)
      Income taxes............        --         --          --       0.42

  Earnings (loss) per share...  $   0.46   $   0.50    $   1.03   $  (0.27)

Dividends per share (after
  giving retroactive effect
  to 100% stock distribution,
  Note 6).....................  $   0.28   $   0.25    $   0.55   $   0.50

Average shares outstanding
  (after giving retroactive
  effect to 100% stock
  distribution, in millions,
  Note 6).....................     212.4      212.4       212.7      212.4


</TABLE>

The accompanying notes to condensed financial statements are an integral part 
of this statement.













				    - 3 -


<PAGE>

		   PPG INDUSTRIES, INC. AND SUBSIDIARIES
<TABLE>
		    Condensed Balance Sheet (Unaudited)
<CAPTION>
						  June 30       Dec. 31
						   1994           1993
							(Millions)
<S>                                              <C>           <C>
Assets                                                  
Current assets:
  Cash and cash equivalents...................   $   52.5      $  111.9
  Receivables-net.............................    1,294.8         996.7
  Inventories (Note 3)........................      694.5         683.3
  Other.......................................      221.1         234.0
    Total current assets......................    2,262.9       2,025.9

Property (less accumulated depreciation of
  $3,340.7 million and $3,254.6 million)......    2,735.7       2,787.3
Investments...................................      303.3         264.5
Other assets..................................      523.0         573.8
    Total.....................................   $5,824.9      $5,651.5

Liabilities and Shareholders' Equity
Current liabilities:
  Short-term borrowings and obligations
    under capital leases......................   $  381.0      $  355.1
  Accounts payable and accrued liabilities....      989.4         921.2
  Income taxes................................        0.1           4.7
    Total current liabilities.................    1,370.5       1,281.0

Long-term debt and obligations under
  capital leases..............................      769.1         774.0
Deferred income taxes.........................      272.0         268.6
Accumulated provisions........................      262.1         282.5
Other postretirement benefits (Note 2)........      518.3         520.4
Minority interest.............................       59.6          51.9
    Total liabilities.........................    3,251.6       3,178.4

Shareholders' equity:
  Common stock (Note 6).......................      484.3         242.1
  Additional paid-in capital (Note 6).........       66.8         297.5
  Retained earnings...........................    3,539.7       3,436.8
  Treasury stock..............................   (1,282.6)     (1,224.7)
  Unearned compensation.......................     (184.2)       (182.5)
  Minimum pension liability adjustment........      (36.2)        (36.1)
  Currency translation adjustment.............      (14.5)        (60.0)
    Total shareholders' equity................    2,573.3       2,473.1

    Total.....................................   $5,824.9      $5,651.5

The accompanying notes to condensed financial statements are an integral part 
of this statement.

</TABLE>
				    - 4 -




		   PPG INDUSTRIES, INC. AND SUBSIDIARIES
<TABLE>
	       Condensed Statement of Cash Flows (Unaudited)
<CAPTION>
						  Six Months Ended June 30
						    1994            1993
							 (Millions)
<S>                                                <C>             <C>
Cash from operations.........................      $ 241.0         $ 248.3

Investing activities:
   Capital spending..........................       (136.8)         (170.4)
   Other.....................................          9.0            41.0
	Cash used for investing activities...       (127.8)         (129.4)

Financing activities:
   Net change in borrowings with
     maturities of three months or less......          9.3           155.5
   Proceeds from other short-term debt.......         19.1             3.4
   Repayment of other short-term debt........        (12.6)           (9.4)
   Proceeds from long-term debt..............          3.8             6.1
   Repayment of long-term debt and capital
     leases..................................        (18.7)         (170.1)
   Loans to employee stock ownership plan....        (11.0)             --
   Repayment of loans by employee stock
     ownership plan..........................          9.3            12.8
   Purchase of treasury stock, net...........        (56.7)          (18.3)
   Dividends paid............................       (116.9)         (106.2)
	Cash provided by
	  financing activities...............       (174.4)         (126.2)

Effect of currency exchange rate changes
  on cash and cash equivalents...............          1.8             (.2)

Net decrease in cash
  and cash equivalents.......................        (59.4)           (7.5)

Cash and cash equivalents,
  beginning of period........................        111.9            61.4

Cash and cash equivalents,
  end of period..............................      $  52.5         $  53.9

</TABLE>

The accompanying notes to condensed financial statements are an integral part 
of this statement.





				    - 5 -


<PAGE>

		   PPG INDUSTRIES, INC. AND SUBSIDIARIES

	    Notes to Condensed Financial Statements (Unaudited)


1.   Financial Statements

The condensed financial statements included herein are unaudited.  In 
the opinion of management, these statements include all adjustments, 
consisting only of normal, recurring adjustments, necessary for a fair 
presentation of the financial position of PPG Industries, Inc. and 
consolidated subsidiaries (the Company or PPG) at June 30, 1994, and the 
results of their operations for the three- and six-month periods ended 
June 30, 1994 and 1993 and their cash flows for the six-month periods 
ended June 30, 1994 and 1993.  These condensed financial statements 
should be read in conjunction with the financial statements and notes 
thereto included in PPG's Annual Report on Form 10-K for the year ended 
December 31, 1993.

The results of operations for the six months ended June 30, 1994 are not 
necessarily indicative of the results to be expected for the full year.

2.   Changes in Methods of Accounting

Effective January 1, 1993, the Company adopted Statement of Financial 
Accounting Standards (SFAS) No. 106, "Employers' Accounting for 
Postretirement Benefits Other Than Pensions."  This standard requires 
accrual, during the years that the employee renders the necessary 
services, of the expected cost of providing postretirement benefits to 
an employee and the employee's covered dependents.  The Company's 
previous practice was to recognize these costs as benefits were paid.  
PPG elected to recognize immediately the cumulative effect of this 
accounting change, which resulted in an after-tax charge of 
$357.1 million (including $6.4 million for an equity affiliate) in 1993.  
The incremental after-tax impact of accruing the cost of these 
postretirement benefits for 1993 was not material.

The Company also adopted SFAS No. 109, "Accounting for Income Taxes," 
effective January 1, 1993.  This standard requires an asset and 
liability approach to accounting for income taxes.  Deferred income tax 
liabilities and assets reflect the tax effects of (1) temporary 
differences between the carrying amount of assets and liabilities for 
financial reporting purposes and the amounts used for income tax 
purposes and (2) operating loss and tax credit carryforwards.  Deferred 
income tax assets, such as benefits related to net operating loss 
carryforwards, are recognized to the extent that realization of such 
benefits is more likely than not.  Changes in enacted tax rates or laws 
result in adjustments to the recorded deferred income tax assets and 
liabilities in the period that the tax law is enacted.



				    - 6 -

<PAGE>


The $90.4 million cumulative effect of this accounting change as of 
January 1, 1993 was credited to income in 1993.  The effect of the  
accounting change on 1993 net income, exclusive of the cumulative effect 
as of January 1, 1993, was not material.  Previously, the Company 
applied the deferral method specified in Accounting Principles Board 
Opinion No. 11 to provide for deferred income taxes with respect to 
timing differences between the recognition of income and expense items 
for financial reporting purposes and income tax purposes.

Effective January 1, 1993, the Company also adopted the provisions of 
SFAS No. 112, "Employers' Accounting for Postemployment Benefits."  This 
standard requires an accrual method of recognizing the cost of 
postemployment benefits, such as disability, severance and workers' 
compensation benefits.  Since the Company previously accounted for most 
of these benefits on an accrual basis, the cumulative after-tax charge 
as of January 1, 1993, of the accounting change was only $6.1 million.  
The incremental after-tax impact of accruing the cost of these benefits 
for 1993 was not material.

3.   Inventories

Inventories at June 30, 1994, and December 31, 1993, are detailed below.
<TABLE>
<CAPTION>
							 June 30     Dec. 31
							  1994        1993
							     (Millions)
<S>                                                      <C>         <C>   
      Finished products and work in process............  $460.6      $451.8
      Raw materials....................................   119.6       117.5
      Supplies.........................................   114.3       114.0

	Total..........................................  $694.5      $683.3
</TABLE>

Most domestic and certain foreign inventories are valued using the last-
in, first-out method.  If the first-in, first-out method had been used, 
inventories would have been $207.6 million and $210.1 million higher at 
June 30, 1994 and December 31, 1993, respectively.

4.   Business Divestitures and Realignments

The impact of the Company's continuing programs to divest or realign 
businesses and activities not meeting strategic or performance 
objectives is reflected in PPG's 1994 and 1993 results.  The related 
charge for 1994 shown in the condensed statement of operations pertains 
to the divestiture of the Biomedical Systems Division and the charges 
for 1993 six-month results pertain principally to the coatings and 
resins segment.  Refer to Management's Discussion and Analysis of 
Financial Condition and Results of Operations for further details 
regarding these charges.




				    - 7 -


<PAGE>

5.   Cash Flow Information

Cash payments for interest for the six months ended June 30, 1994 and 
1993 were $49.9 million and $60.6 million, respectively.  Cash payments 
for income taxes for the six months ended June 30, 1994 and 1993 were 
$143.9 million and $142.0 million, respectively.

6.   Stock Split

On April 21, 1994, the Board of Directors approved a two-for-one stock 
split in the form of a 100% stock distribution.  The distribution was 
made on June 10, 1994, to shareholders of record as of May 10, 1994.  
Share and per share data give retroactive effect to the stock split.

7.   Business Segment Information
<TABLE>
<CAPTION>
				   Three Months            Six Months
				   Ended June 30          Ended June 30
				  1994       1993        1994       1993
						(Millions)
<S>                              <C>        <C>         <C>        <C>
     Net Sales

	  Coatings and Resins    $  695     $  615      $1,316     $1,188
	  Glass                     617        575       1,185      1,126
	  Chemicals                 307        291         595        573
	  Other                      --         42          --         83
	    Total                $1,619     $1,523      $3,096     $2,970

     Operating Earnings

	  Coatings and Resins    $  143     $  121      $  267     $  220
	  Glass                      93         55         169        111
	  Chemicals                  35         38          71         81
	  Other (1)                 (84)        (5)        (81)        (9)
	    Total operating
	     income                 187        209         426        403

     Interest - net                 (20)       (22)        (40)       (47)

     Other unallocated corporate
       (expense) income - net        (6)        (3)        (15)        15

     Income before income taxes
       and minority interest     $  161     $  184      $  371     $  371


<FN>
	  (1) Included in this segment's 1994 operating income 
	      was an $85 million divestment charge to exit the 
	      Biomedical Systems Division (see Note 4).
</TABLE>


				   - 8 -


<PAGE>

8.   Environmental Matters

Management of the Company currently does not anticipate that the 
resolution of the environmental contingencies detailed below, which will 
occur over an extended period of time, will result in the Company 
recording future annual charges to income that are significantly greater 
than those recorded in recent years.  It is possible, however, that 
technological, regulatory and enforcement developments, the results of 
environmental studies and other factors, could alter this expectation.  
In management's opinion, the Company operates in an environmentally 
sound manner and the outcome of these environmental matters will not 
have a material effect on PPG's financial position or liquidity.  To 
date, compliance with Federal, state and local requirements has not had 
a material impact on PPG's financial position, results of operations or 
liquidity.

It is PPG's policy to accrue expenses for environmental contingencies 
when it is probable that a liability exists and the amount of loss can 
be reasonably estimated.  As of June 30, 1994 and December 31, 1993, PPG 
had environmental reserves totaling $84 million and $90 million, 
respectively.  Charges against income for environmental remediation 
costs for the six month periods ended June 30, 1994 and 1993 were 
$13 million and $9 million, respectively.

In addition to the amounts accrued, the Company may be subject to 
contingencies related to environmental matters estimated at the high end 
to be as much as $200 million to $400 million.  Such aggregate losses 
are reasonably possible but not currently considered to be probable of 
occurrence.  These contingencies include significant unresolved issues 
including the nature and extent of contamination, if any, at sites and 
the methods that may have to be employed should remediation be required.  
At certain waste sites, the financial condition of any other potentially 
responsible parties also contributes to the uncertainty of estimating 
PPG's final costs.  Although contributors of waste to sites involving 
other potentially responsible parties may face governmental agency 
assertions of joint and several liability, in general, final allocations 
of costs are made based on the relative contributions of wastes to such 
sites.  PPG is generally not a major contributor to such sites.  The 
extent to which costs incurred are recoverable from insurance companies 
is also a factor in determining PPG's ultimate cost.  Although the 
unrecorded exposure to future loss relates to all sites, a significant 
portion of such unrecorded exposure involves three operating plant sites 
and one closed plant site.  Two of the sites are in the early stages of 
study while the remaining two are further into the study phase.  All 
four sites require further study in order to assess the magnitude of 
contamination, if any, and the viable remediation alternatives.  It is 
expected that the Company's environmental contingencies will be resolved 
over a period of 20 years or more.





				    - 9 -


<PAGE>

Item 2.  Management's Discussion and Analysis of Financial
	 Condition and Results of Operations

Performance in the Second Quarter of 1994 Compared to the Second Quarter of 
1993

Performance Overview

Sales for the second quarter of 1994 and 1993 were $1.62 billion and 
$1.52 billion, respectively.  Higher volumes in each of the business segments, 
including sales from the January 1994 acquisition of Akzo's European original 
equipment auto coatings business, more than offset the absence of sales in 
1994 from the Biomedicals Systems Division and glass businesses which were 
divested or discontinued, or are expected to be divested or discontinued 
within the next six months.  The unfavorable effect of translating European 
currencies, and lower overall prices in the Chemicals segment, negatively 
impacted sales.

The gross profit percentage increased to 39.0% from 36.6% in the prior year's 
quarter.  Contributing factors to the improvement were lower manufacturing 
costs, sales mix gains, and benefits from divested and discontinued businesses 
and businesses to be divested or discontinued. Lower overall sales prices in 
the Chemicals segment and the negative effects of inflation partly offset 
these gains.

On April 21, 1994, the Board of Directors approved a two-for-one stock split 
in the form of a 100% stock distribution.  The distribution was made on 
June 10, 1994 to shareholders of record on May 10, 1994.  Share and per share 
data give retroactive effect to the stock split.

Net income and earnings per share for the quarter were $96.2 million and 
$0.46, respectively.  In the second quarter of 1993, net income and earnings 
per share were $106.2 million and $0.50, respectively.  Included in the 
current period results was a $52 million after-tax charge related to the 
divestment of the Company's Biomedical Systems Division.  Higher environmental 
study costs and charges related to the relocation of an administrative office 
also negatively impacted earnings.  Partially offsetting these charges were 
the factors that contributed to the gross profit percentage  improvement, 
higher sales volumes, and lower income tax expense principally as a result of 
the lower amount of income before income taxes and minority interest.

Performance of Business Segments

Coatings and resins sales increased to $695 million from $615 million for the 
second quarter of 1993.  Operating earnings for the corresponding periods were 
$143 million and $121 million, respectively.  Contributing to the sales 
increase were higher volumes for most of the segment's major product lines, 
including sales from the January 1994 acquisition of the Akzo coatings 
business and slightly higher overall prices, principally from refinish 
coatings.  The unfavorable effect of translating European currencies partially 
offset these sales gains.  The increase in operating earnings was attributable 
   


				    - 10 -


<PAGE>

to the factors that contributed to the higher sales as well as benefits from 
manufacturing efficiencies.  Higher overhead costs partly offset these 
improvements.

Glass sales increased to $617 million in the second quarter of 1994 from 
$575 million in the prior year period.  Operating income increased to 
$93 million from $55 million in the corresponding prior period.  Higher 
volumes in each of the segment's major businesses and higher sales prices for 
North American flat and automotive replacement glass and fiber glass 
reinforcements contributed to the sales increase.  The absence of sales from 
divested and discontinued businesses, the unfavorable effects of translating 
European currencies, and reduced prices for North American automotive original 
and European flat glass and fiber glass reinforcement products partially 
offset these improvements.  The increase in operating earnings was principally 
the result of benefits from manufacturing efficiencies, the absence of 
operating losses from divested and discontinued businesses, and the factors 
that contributed to the sales increase.  The negative effects of inflation 
partially offset these improvements.

Chemical sales increased to $307 million from $291 million in the second 
quarter of 1993 while operating earnings declined to $35 million from 
$38 million for the corresponding prior period.  The increase in sales is 
primarily attributable to higher volumes for most chlor-alkali and specialty 
chemical products and increased chlorine prices.  Significantly offsetting 
these improvements were lower caustic soda and chlorine derivative prices.  
The lower operating earnings were the result of lower overall sales prices, 
higher environmental study costs, and the unfavorable effects of inflation, 
offset in part by the higher sales volumes and manufacturing efficiencies.

Included in the "other" segment's operating income was an $85 million charge 
related to the divestment of the Biomedical Systems Division.  Because of the 
general decline in health care and related markets, and other uncertainties, 
disposition of the remaining assets of this division may not occur within one 
year of the Company's original decision to divest it. The majority of the 
charge was comprised of the reversal of a $60 million gain originally 
anticipated from divestiture of its sensors business at the time the decision 
was made to dispose of the division.  Also, a $13 million charge was taken for 
additional operating losses anticipated through the expected disposal date 
resulting from such date being extended as well as actual operating losses 
exceeding those originally estimated.  Any gains on sales of the remaining 
assets will be recognized in the period in which they occur.

With the exception of the charge recorded in the second quarter of 1994 
related to the disposition of the Biomedicals Systems Division discussed 
above, there have not been significant changes in the Company's plans for 
implementing business divestiture and realignment programs undertaken in prior 
years.  







				   - 11 -
<PAGE>



Performance in the First Six Months of 1994 Compared to the First Six Months 
of 1993

Performance Overview

Sales for the first six months of 1994 and 1993 were $3.1 billion and 
$3.0 billion, respectively.  Higher volumes in each of the business segments 
more than offset the absence of sales in 1994 from the Biomedicals Systems 
Division and glass businesses which were divested or discontinued, or are 
expected to be divested or discontinued within the next six months.  The 
unfavorable effect of translating European currencies, and lower overall 
prices in the Chemicals segment, negatively impacted sales.

The gross profit percentage increased to 38.6% from 36.7% in the prior year's 
quarter.  Contributing factors to the improvement were lower manufacturing 
costs, sales mix gains, and benefits from divested and discontinued businesses 
and businesses to be divested or discontinued. Lower overall sales prices in 
the Chemicals segment and the negative effects of inflation partly offset 
these gains.

Net income and earnings per share for the current year period were 
$218.1 million and $1.03, respectively.  In the prior year period, the Company 
experienced a net loss and loss per share of $56.5 million and $0.27, 
respectively.  The prior year amounts included a net charge of $272.8 million 
or $1.29 per share for three accounting changes (see Note 2 to the condensed 
financial statements).  Also included was an 8 cent per share gain from the 
sale of our interest in an insurance company.  Current period earnings were 
favorably impacted by the factors that contributed to the gross profit 
percentage  improvement, higher sales volumes, and lower interest expense.  
Partly offsetting these gains was the $52 million after-tax charge related to 
the exit of the Biomedical Systems Division and the recording of a charge for 
relocation of an administrative office.

Performance of Business Segments

Coatings and resins sales increased to $1.32 billion from $1.19 billion for 
the first six months of 1993.  Operating earnings for the corresponding 
periods were $267 million and $220 million, respectively.  Contributing to the 
sales increase were higher volumes for each of the segment's major product 
lines, including sales from the January 1994 acquisition of the Akzo coatings 
business and slightly higher overall prices, principally from refinish 
coatings.  The unfavorable effect of translating European currencies partially 
offset these sales gains.  The increase in operating earnings was attributable 
to the factors that contributed to the higher sales as well as benefits from 
manufacturing efficiencies.  Higher overhead costs partly offset these 
improvements.

Glass sales increased to $1.19 billion in the six-month period ended June 30, 
1994, from $1.13 billion in the prior year period.  Operating income increased 
to $169 million from $111 million in the corresponding prior period.  Higher 
volumes in each of the segment's major businesses and higher sales prices for 
North American flat and automotive replacement glass and fiber glass 
	  

				   - 12 -


<PAGE>

reinforcements contributed to the sales increase.  The absence of sales from 
divested and discontinued businesses, the unfavorable effects of translating 
European currencies, and reduced prices for North American automotive original 
and European fiber glass reinforcement and flat glass products offset these 
improvements.  The operating earnings improvement was principally the result 
of improved volumes, manufacturing efficiencies, and the absence of operating 
losses from certain businesses being divested or discontinued.

Chemical sales increased to $595 million from $573 million for the six-month 
period ended June 30, 1993, while operating earnings declined to $71 million 
from $81 million for the corresponding prior period.  The increase in sales is 
primarily attributable to higher volumes for most chlor-alkali, chlorine 
derivative, and specialty chemical products.  Significantly offsetting these 
improvements were lower chlor-alkali prices.  The lower operating earnings 
were the result of lower chlor-alkali sales prices, higher environmental 
remediation costs, and the negative effects of inflation, offset in part by 
the higher sales volumes and manufacturing efficiencies.

As discussed above, included in the "other" segment's operating income was an 
$85 million charge related to the divestment of the Biomedical Systems 
Division.

Other Factors

The decline in interest expense was the result of lower average borrowings and 
interest rates for the second quarter of 1994 and six-month period ended 
June 30, 1994, as compared with the corresponding periods in 1993.

Higher other charges for the second quarter of 1994 was principally the result 
of higher environmental study costs and charges incurred for the relocation of 
an administrative office.

Lower other earnings and the change in other unallocated corporate (expense) 
income - net for the six-month period ended June 30, 1994, were principally 
the result of the absence of the gain  from the sale of our interest in an 
insurance company, which occurred in the first quarter of 1993.

The increase in accounts receivable is principally the result of higher sales 
in June 1994 as compared with those in December 1993 as well as a seasonal 
granting of extended credit terms to customers.

The decline in accumulated provisions and other assets is principally 
attributable to the sale of the European portion of our Biomedical Systems 
Division.

Environmental Matters

Management of the Company currently does not anticipate that the resolution of 
the environmental contingencies detailed below, which will occur over an 
extended period of time, will result in the Company recording future annual 
charges to income that are significantly greater than those recorded in recent 
years.  It is possible, however, that technological, regulatory and 
	   

				   - 13 -


<PAGE>

enforcement developments, the results of environmental studies and other 
factors, could alter this expectation.  In management's opinion, the Company 
operates in an environmentally sound manner and the outcome of these 
environmental matters will not have a material effect on PPG's financial 
position or liquidity.  To date, compliance with Federal, state and local 
requirements has not had a material impact on PPG's financial position, 
results of operations or liquidity.

It is PPG's policy to accrue expenses for environmental contingencies when it 
is probable that a liability exists and the amount of loss can be reasonably 
estimated.  As of June 30, 1994 and December 31, 1993, PPG had environmental 
reserves totaling $84 million and $90 million, respectively.  Charges against 
income for environmental remediation costs for the six month periods ended 
June 30, 1994 and 1993 were $13 million and $9 million, respectively.

In addition to the amounts accrued, the Company may be subject to 
contingencies related to environmental matters estimated at the high end to be 
as much as $200 million to $400 million.  Such aggregate losses are reasonably 
possible but not currently considered to be probable of occurrence.  These 
contingencies include significant unresolved issues including the nature and 
extent of contamination, if any, at sites and the methods that may have to be 
employed should remediation be required.  At certain waste sites, the 
financial condition of any other potentially responsible parties also 
contributes to the uncertainty of estimating PPG's final costs.  Although 
contributors of waste to sites involving other potentially responsible parties 
may face governmental agency assertions of joint and several liability, in 
general, final allocations of costs are made based on the relative 
contributions of wastes to such sites.  PPG is generally not a major 
contributor to such sites.  The extent to which costs incurred are recoverable 
from insurance companies is also a factor in determining PPG's ultimate cost.  
Although the unrecorded exposure to future loss relates to all sites, a 
significant portion of such unrecorded exposure involves three operating plant 
sites and one closed plant site.  Two of the sites are in the early stages of 
study while the remaining two are further into the study phase.  All four 
sites require further study in order to assess the magnitude of contamination, 
if any, and the viable remediation alternatives.  It is expected that the 
Company's environmental contingencies will be resolved over a period of 20 
years or more.

Foreign Currency and Interest Rate Risk

As a multinational company, PPG is concerned with, and therefore manages, its 
transaction exposure to foreign currency risk.  Its objective in managing this 
risk is to minimize the volatility of cash flows due to currency fluctuations.  
The Company manages its foreign currency exposures principally through the 
purchase of forward and option contracts.  It does not manage its exposure to 
translation gains and losses; however, by borrowing in local currencies it 
reduces such exposure.  The market value of the forward and option contracts 
purchased and outstanding as of June 30, 1994, was not material.






				   - 14 -

<PAGE>


The Company manages its interest rate risk in order to balance its exposure 
between fixed and variable rates while attempting to minimize its interest 
costs.  PPG principally manages its interest rate risk by means of retiring 
and issuing debt from time to time.  To a limited extent, PPG manages its 
interest rate risk through the purchase of interest rate swaps.  As of 
December 31, 1993 and June 30, 1994 the notional principal amounts and fair 
values of interest rate swaps held were immaterial.

PPG's policies do not permit active trading of currency or interest rate 
derivatives.

Additional Business Divestiture and Realignment Detail

1991 Business Divestitures and Realignments

In 1991, the Company recorded business divestiture and realignment charges 
totaling $84 million.  Of the charges, $68 million related to the glass 
segment, $13 million related to the coatings and resins segment, $2 million 
related to the chemicals segment and $1 million related to the "other" 
segment.  

Of the glass segment charges, approximately $42 million was recorded to write 
down certain assets at two plants to reflect the segment's inability to 
recover the carrying value of such impaired assets.  A $12 million charge was 
also taken with respect to the idling of these facilities, for a period of 
approximately 3 years, due to overcapacity in the North American flat glass 
industry and the lack of demand for glass products produced at those plants.  
These actions were taken in response to results from internal and external 
studies which analyzed the performance aspect of these facilities and a 
related impairment analysis, which were completed in the first quarter of 
1991.  The remainder of the charges relate principally to a work force 
reduction program which was initiated to streamline the segment's flat glass 
organization.  

The charge recorded by the coatings and resins segment principally related to 
streamlining of each of its operations throughout North America and 
reorganization of the North American architectural finishes business.  

In addition to the $42 million impairment charge, the provisions recorded were 
principally comprised of severance costs totaling $38 million and the cost of 
long-term contractual obligations principally related to the two glass 
facilities during the period they were idle of $7 million. 

1993 Business Divestitures and Realignments

In 1993, the Company recorded business divestiture and realignment charges 
totaling $126 million.  Of these charges, $78 million related to the glass 
segment, $38 million related to the "other" segment involving our Biomedicals 
Systems Division and $5 million each related to the coatings and resins and 
the chemicals segments.  




				   - 15 -


<PAGE>

Of the glass segment's charges, approximately $71 million related to the shut-
down of two manufacturing facilities, the discontinuation of the commercial 
products business, and the disposition of the architectural metals business. 
One of the manufacturing facilities, which had previously been temporarily 
idled, was permanently closed because management concluded that the market for 
its products would not support operation of the facility.  Management also 
decided to close the second facility because of the segment's overcapacity for 
the plant's manufactured products.  Operating earnings could be increased 
through the reallocation of its production to more efficient facilities.  The 
decision to exit the commercial products business was due principally to its 
disappointing operating performance.  The architectural metals business was 
sold because it was not a core operation of the glass segment and it also 
experienced unfavorable operating results. 

Since the Company's acquisition of the Biomedicals Systems Division, it has 
consistently reported disappointing operating results.  Moreover, this 
business had not blended well with PPG's other major segments and proved to be 
difficult to manage under the continually changing business environment in 
which it operated.  As a result, management decided early in the fourth 
quarter of 1993 to divest and a charge of $38 million was recorded in that 
quarter.  The charge was principally based on anticipated sales proceeds from 
the divestiture of the sensors and medical electronics businesses of 
approximately $65 million and $50 million, respectively.  Such amounts 
resulted in an estimated net loss of $5 million.  In addition, $30 million of 
operating losses were anticipated through the expected disposal date.

In addition to the components of the Biomedicals Systems Division provision 
detailed above, significant components of the business divestiture and 
realignment charges included charges for the retirement or write-off of 
operating assets with net book values of approximately $31 million, severance 
and benefit costs of $17 million, incremental workers' compensation accruals 
of $10 million, environmental accruals of $9 million, anticipated future 
operating losses of $6 million through the expected disposal dates for the 
commercial products and architectural metals businesses, and charges of 
approximately $2 million for the disposition of operating assets (net of 
anticipated sales proceeds of $16 million).

The charges recorded in 1993 are expected to be recovered in the future to a 
large extent through the absence of historical operating losses for the 
Biomedical Systems Division.  Such operating losses were approximately 
$61 million, $13 million, and $23 million for 1993, 1992 and 1991, 
respectively.  In addition, future annual operating earnings are projected to 
be positively impacted by approximately $10 million primarily as a result of 
the elimination of various operating costs.  With the exception of sales 
proceeds expected in 1994 from the divestiture of the Biomedicals Systems 
Division's sensors and medical electronics businesses, the cash flow effect of 
these 1993 activities are not anticipated to be significant.  Sales proceeds 
received to date in 1994 have consisted of $5 million in cash plus $11 million 
in securities and receivables. 





				   - 16 -

<PAGE>


		       Part II.  OTHER INFORMATION

Item 6.   Exhibits and Reports on Form 8-K

     (a)  Exhibits

	  (11)  Computation of Earnings Per Share

     (b)  Reports on Form 8-K

	  The Company filed a Form 8-K on April 21, 1994.  The report 
	  indicated that on that date the registrant's Board of Directors 
	  raised the registrant's quarterly dividend on its common stock to
	  56 cents per share and approved a two-for-one common stock split
	  in the form of a 100% stock distribution.  The cash dividend and
	  stock distribution were made on June 10, 1994 to shareholders of
	  record as of May 10, 1994.  The quarterly common stock 
	  dividend was 28 cents per share on an after-split basis.



































				   - 17 -


<PAGE>

				 SIGNATURE





Pursuant to the requirements of the Securities Exchange Act of 1934, the 
Registrant has duly caused this report to be signed on its behalf by the 
undersigned thereunto duly authorized.





						  PPG INDUSTRIES, INC.     
						      (Registrant)





Date:     August 15, 1994                       /s/ W. H. Hernandez        
						    W. H. Hernandez      
					     Vice President and Controller
					    (Acting Principal Financial and
					       Accounting Officer and
					       Duly Authorized Officer)



























				   - 18 -


<PAGE>





		   PPG INDUSTRIES, INC. AND SUBSIDIARIES

			     INDEX TO EXHIBITS



Exhibit
  No.              Description             


  11            Computation of Earnings (Loss) Per Share




<PAGE>                                                                 
								 Exhibit 11



		   PPG INDUSTRIES, INC. AND SUBSIDIARIES
<TABLE>
		 Computation of Earnings (Loss) Per Share

<CAPTION>
				   Three Months            Six Months
				   Ended June 30          Ended June 30
				  1994       1993        1994       1993
<S>                             <C>        <C>         <C>        <C>
Income before cumulative
  effect of accounting
  changes.....................  $  96.2    $ 106.2     $ 218.1    $ 216.3

Cumulative effect of
  accounting changes:
  Other postretirement
    and postemployment
    benefits..................       --         --          --     (363.2)
  Income taxes................       --         --          --       90.4

Net income (loss).............  $  96.2    $ 106.2     $ 218.1    $ (56.5)

Weighted average number of
  shares of common stock
  outstanding.................    212.4      212.4       212.7      212.4

Weighted average number of
  shares of common stock
  outstanding and common
  stock equivalents..........     214.0      214.0       214.3      213.8

Primary earnings (loss)
  per share:

  Income before cumulative
    effect of accounting
    changes..................   $  0.46    $  0.50     $  1.03    $  1.02

  Cumulative effect of
    accounting changes:
    Other postretirement
      and postemployment
      benefits................       --         --          --      (1.71)
    Income taxes..............       --         --          --       0.42

  Earnings (loss) per share...  $  0.46    $  0.50     $  1.03    $ (0.27)


</TABLE>

<PAGE>

								 Exhibit 11



		   PPG INDUSTRIES, INC. AND SUBSIDIARIES
<TABLE>
		 Computation of Earnings (Loss) Per Share
<CAPTION>
				(Continued)


				   Three Months            Six Months
				   Ended June 30          Ended June 30
				  1994       1993        1994       1993
<S>                             <C>        <C>         <C>        <C>
Fully diluted earnings (loss)
  per share:

  Income before cumulative
    effect of accounting
    changes...................  $  0.45    $  0.50     $  1.02    $  1.01

  Cumulative effect of
    accounting changes:
    Other postretirement
      and postemployment
      benefits................       --         --          --      (1.69)
    Income taxes..............       --         --          --       0.42

  Earnings (loss) per share...  $  0.45    $  0.50     $  1.02    $ (0.26)

<FN>

NOTES:

Share and per share data give retroactive effect to the two-for-one stock 
split in the form of a 100% stock distribution which was made on June 10, 
1994.

The common stock equivalents consist of the shares reserved for issuance under 
PPG's stock option plan and deferred under PPG's incentive compensation, 
management award, earnings growth and directors' retirement plans.

The fully diluted earnings (loss) per share calculations are submitted in 
accordance with Regulation S-K item 601(b)(11) although not required by 
footnote 2 to paragraph 14 of APB Opinion No. 15 because they result in 
dilution of less than three percent.

All amounts are in millions except per share data.

</TABLE>


 





© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission